{"id":6078,"date":"2018-02-11T21:22:03","date_gmt":"2018-02-11T21:22:03","guid":{"rendered":"https:\/\/www.ftcguardian.com\/articles\/?p=6078"},"modified":"2018-02-11T21:22:03","modified_gmt":"2018-02-11T21:22:03","slug":"ny-sues-fentanyl-drug-maker-for-75m","status":"publish","type":"post","link":"https:\/\/www.ftcguardian.com\/articles\/ny-sues-fentanyl-drug-maker-for-75m\/","title":{"rendered":"NY sues fentanyl drug maker for $75M"},"content":{"rendered":"<h1 class=\"name post-title entry-title\">NY sues fentanyl drug maker for $75M<\/h1>\n<p>By\u00a0<a href=\"https:\/\/libn.com\/2018\/02\/01\/ny-sues-fentanyl-drug-maker-for-75m\/\">Claude Solnik<\/a><\/p>\n<p>New York State Attorney General\u2019s office has filed a lawsuit charging that Insys Therapeutics used false advertising to market Subsys, a drug that includes fentanyl, a highly addictive drug.<\/p>\n<p><a class=\"popup_7TLM_Cheat_Sheet\" data-toggle=\"modal\" data-target=\"#popup_7TLM_Cheat_Sheet_modal\" href=\"#\"><img decoding=\"async\" class=\"aligncenter\" src=\"\/images\/button_banner-7TLM_Cheat_Sheet.png\" alt=\"\" \/><\/a><\/p>\n<p>The law suit argues that while Subsys was approved by the Food and Drug Administration \u00a0to treat severe cancer-related pain, Insys marketed it for a much wider use, covering a broader set of patients.<\/p>\n<p>New York State also argues that Insys used a \u201cpattern of deceptive and illegal conduct by downplaying the drug\u2019s risks of addiction, bribing doctors to prescribe the drug \u00a0and lying to healthcare providers to skirt their authorization process.\u201d<\/p>\n<p>The attorney general\u2019s office is seeking $75 million including penalties and disgorgement of revenues accumulated during the period of alleged misconduct.<\/p>\n<p>Read full article and learn more about <a href=\"https:\/\/libn.com\/2018\/02\/01\/ny-sues-fentanyl-drug-maker-for-75m\/\">Deceptive Advertising here<\/a>.<\/p>\n<p><a href=\"http:\/\/go.ftcguardian.com\/bw4uoy\"><img decoding=\"async\" src=\"https:\/\/s3.amazonaws.com\/ftcguardian\/images\/728x90-Un-vjy-FTC-GUARDIAN-banner-2.gif\" \/><\/a><\/p>\n<h2>Here\u2019s How To Make Sure You,\u00a0Your Business & Website Is FTC Compliant<\/h2>\n<p>By now it should be clear how important it is for you to be FTC compliant. But how can you do that without spending $7,500-$8,000 or more on Internet Attorneys?<\/p>\n<p>Smart business owners around the world are doing it with the help of FTC Guardian.<\/p>\n<p>FTC Guardian is a service that is 100% focused on helping to keep you get and stay FTC compliant and fully protected.\u00a0<a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener noreferrer\">And right now, we are offering a free training to give you the knowledge, information, and guidance that you need to stay out of trouble with the Federal Trade Commission.<\/a><\/p>\n<p>Free Compliance Workshop:\u00a0<a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener\"><strong>Join Chip Cooper, Esq., the #1 FTC Compliance trainer in the World, for a one-of-kind, completely free online compliance workshop. Workshops fill up quickly, so register now.<\/strong><\/a><\/p>\n<p>Here are some of the things you\u2019ll discover on the training:<\/p>\n<ul>\n<li>Real-Life Examples of People Who Didn\u2019t Think They Were At Risk, But Who Got Nailed By The FTC, And Why It Could Happen To You, Too<\/li>\n<\/ul>\n<ul>\n<li>The 3 Enormous Powers The FTC Has That Can Change Your Life \u2013 And Your Family\u2019s Life \u2013 Forever!<\/li>\n<\/ul>\n<ul>\n<li>How to Avoid FTC Claims When Collecting Leads With Optin Forms<\/li>\n<\/ul>\n<ul>\n<li>3 Privacy Policy Mistakes Every Digital Marketer Is Making, And Why You\u2019re In The FTC\u00a0Crosshairs.<\/li>\n<\/ul>\n<ul>\n<li>And Much More\u2026<\/li>\n<\/ul>\n<p><b>Remember: legal protection is a massively important part of your business, and it\u2019s one you cannot afford to ignore any longer.<\/b><\/p>\n<p><a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener noreferrer\">Go here to register for our next FREE training and make your business is FTC compliant today!<\/a><\/p>\n<p><b>Disclaimer: \u00a0This article is provided for informational purposes only. It\u2019s not legal advice, and no attorney-client relationship is created. Neither the author nor FTC Guardian, Inc. is endorsed by the Federal Trade Commission.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NY sues fentanyl drug maker for $75M By\u00a0Claude Solnik New York State Attorney General\u2019s office has filed a lawsuit charging that Insys Therapeutics used false advertising to market Subsys, a drug that includes fentanyl, a highly addictive drug. The law &hellip;  <\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_analytify_skip_tracking":false,"footnotes":""},"categories":[19,2,12,29],"tags":[11,33,21,30],"class_list":["post-6078","post","type-post","status-publish","format-standard","hentry","category-deceptive-advertising","category-ftc-claims","category-ftc-compliance","category-truth-in-advertising","tag-ad-claims","tag-advertising","tag-deceptive-advertising","tag-truth-in-advertising"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/6078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/comments?post=6078"}],"version-history":[{"count":3,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/6078\/revisions"}],"predecessor-version":[{"id":6101,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/6078\/revisions\/6101"}],"wp:attachment":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/media?parent=6078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/categories?post=6078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/tags?post=6078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}